These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1624 related items for PubMed ID: 11283125

  • 1. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F, Suciu S, Philippe N, Benoit Y, Mazingue F, Uyttebroeck A, Lutz P, Mechinaud F, Robert A, Boutard P, Marguerite G, Ferster A, Plouvier E, Rialland X, Behard C, Plantaz D, Dresse MF, Philippet P, Norton L, Thyss A, Dastugue N, Waterkeyn C, Vilmer E, Otten J, Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer.
    J Clin Oncol; 2001 Apr 01; 19(7):1935-42. PubMed ID: 11283125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ, Blatt J, Sather HN, Meadows AT.
    Med Pediatr Oncol; 1996 Jul 01; 27(1):15-20. PubMed ID: 8614385
    [Abstract] [Full Text] [Related]

  • 10. Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
    Reiter A.
    Baillieres Clin Haematol; 1994 Jun 01; 7(2):321-37. PubMed ID: 7803904
    [Abstract] [Full Text] [Related]

  • 11. Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.
    Laver JH, Barredo JC, Amylon M, Schwenn M, Kurtzberg J, Camitta BM, Pullen J, Link MP, Borowitz M, Ravindranath Y, Murphy SB, Shuster J.
    Leukemia; 2000 Mar 01; 14(3):369-73. PubMed ID: 10720128
    [Abstract] [Full Text] [Related]

  • 12. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
    Nachman J, Sather HN, Cherlow JM, Sensel MG, Gaynon PS, Lukens JN, Wolff L, Trigg ME.
    J Clin Oncol; 1998 Mar 01; 16(3):920-30. PubMed ID: 9508174
    [Abstract] [Full Text] [Related]

  • 13. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children.
    Patte C, Philip T, Rodary C, Zucker JM, Behrendt H, Gentet JC, Lamagnère JP, Otten J, Dufillot D, Pein F.
    J Clin Oncol; 1991 Jan 01; 9(1):123-32. PubMed ID: 1985161
    [Abstract] [Full Text] [Related]

  • 14. Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.
    Rizzari C, Valsecchi MG, Aricò M, Conter V, Testi A, Barisone E, Casale F, Lo Nigro L, Rondelli R, Basso G, Santoro N, Masera G, Associazione Italiano Ematologia Oncologia Pediatrica.
    J Clin Oncol; 2001 Mar 01; 19(5):1297-303. PubMed ID: 11230471
    [Abstract] [Full Text] [Related]

  • 15. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia.
    Winick NJ, Bowman WP, Kamen BA, Roach ES, Rollins N, Jacaruso D, Buchanan GR.
    J Natl Cancer Inst; 1992 Feb 19; 84(4):252-6. PubMed ID: 1734087
    [Abstract] [Full Text] [Related]

  • 16. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
    Kaleita TA, Reaman GH, MacLean WE, Sather HN, Whitt JK.
    Cancer; 1999 Apr 15; 85(8):1859-65. PubMed ID: 10223582
    [Abstract] [Full Text] [Related]

  • 17. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
    Bowman WP, Shuster JJ, Cook B, Griffin T, Behm F, Pullen J, Link M, Head D, Carroll A, Berard C, Murphy S.
    J Clin Oncol; 1996 Apr 15; 14(4):1252-61. PubMed ID: 8648381
    [Abstract] [Full Text] [Related]

  • 18. Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study.
    Mahoney DH, Shuster JJ, Nitschke R, Lauer S, Steuber CP, Camitta B.
    J Clin Oncol; 2000 Mar 15; 18(6):1285-94. PubMed ID: 10715299
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group.
    Termuhlen AM, Smith LM, Perkins SL, Lones M, Finlay JL, Weinstein H, Gross TG, Abromowitch M.
    Br J Haematol; 2013 Sep 15; 162(6):792-801. PubMed ID: 23889312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.